RhinoCyte Cells

Drug Name: RhinoCyte Cells
Company: RhinoCyte
Location: US-Kentucky
Website: http://www.rhinocyte.com/
Drug Type: Stem Cell Therapy
Conditions: ALS, Parkinson’s disease, multiple sclerosis, spinal cord injury.
Mechanism Type: Neuroprotection
Mechanism: RhinoCyte develops therapies based on autologous adult olfactory-derived neural progenitor stem cells (RhinoCytes). It is unclear whether this program is active.
U.S. Status for ALS: Preclinical

References:
[1] RhinoCyte – Our Research. RhinoCyte, 2016. Accessed 11 Mar 2016 from http://www.rhinocyte.com/.
[2] Human adult olfactory neural progenitors promote axotomized rubrospinal tract axonal reinnervation and locomotor recovery. Xiao M et al. Neurobiol Dis. 2007 May;26:363-374.

Last updated March 11th, 2016

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail